The endogenous capacity to produce proinflammatory mediators by the ex vivo human perfused lung.
Aleksandra LeligdowiczJames T RossNicolas NesselerMichael A MatthayPublished in: Intensive care medicine experimental (2020)
The ex vivo-perfused lung has a marked endogenous capacity to produce inflammatory mediators over the course of short-term perfusion that is not significantly influenced by donor lung characteristics or the presence of exogenous blood, and only minimally affected by the introduction of systemic bacteremia. The lack of association between biomarker change and donor lung cold ischemia time, final alveolar fluid clearance, and experimental percent weight gain suggests that the maintained ability of the human lung to produce biomarkers is not merely a marker of lung epithelial or endothelial injury, but may support the function of the lung as an immune cell reservoir.